Screener
Alto Neuroscience ANRO Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: Alto Neuroscience’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001999480-26-000012
| Line item | Three months ended March 31, 2026 | Three months ended March 31, 2025 |
|---|---|---|
| Total operating expenses | 27,138 | 15,676 |
| Loss from operations | (27,138) | (15,676) |
| Other income (expense): | ||
| Interest income | 1,561 | 1,827 |
| Interest expense | (545) | (598) |
| Loss on debt extinguishment | — | (681) |
| Other, net | (115) | (41) |
| Total other income, net | 901 | 507 |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Alto Neuroscience's interest income?
- Alto Neuroscience (ANRO) reported interest income of $1.56M in Q1 2026.
- How has Alto Neuroscience's interest income changed year-over-year?
- Alto Neuroscience's interest income decreased by 14.6% year-over-year, from $1.83M to $1.56M.
- What is the long-term trend for Alto Neuroscience's interest income?
- Over 2 years (2023 to 2025), Alto Neuroscience's interest income has grown at a 67.7% compound annual growth rate (CAGR), from $2.35M to $6.6M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Alto Neuroscience's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude